These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9028712)

  • 1. Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture.
    Wentzel P; Thunberg L; Eriksson UJ
    Diabetologia; 1997 Jan; 40(1):7-14. PubMed ID: 9028712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free radical scavenging enzymes in fetal dysmorphogenesis among offspring of diabetic rats.
    Sivan E; Lee YC; Wu YK; Reece EA
    Teratology; 1997 Dec; 56(6):343-9. PubMed ID: 9485543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 8-Iso-PGF(2alpha) administration generates dysmorphogenesis and increased lipid peroxidation in rat embryos in vitro.
    Wentzel P; Eriksson UJ
    Teratology; 2002 Oct; 66(4):164-8. PubMed ID: 12353212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of rat embryos in culture media containing different concentrations of normal and diabetic rat serum.
    Styrud J; Eriksson UJ
    Teratology; 1992 Nov; 46(5):473-83. PubMed ID: 1462252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Acetylcysteine and alpha-cyano-4-hydroxycinnamic acid alter protein kinase C (PKC)-delta and PKC-zeta and diminish dysmorphogenesis in rat embryos cultured with high glucose in vitro.
    Gäreskog M; Wentzel P
    J Endocrinol; 2007 Jan; 192(1):207-14. PubMed ID: 17210758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced SOD activity and increased neural tube defects in embryos of the sensitive but not of the resistant Cohen diabetic rats cultured under diabetic conditions.
    Weksler-Zangen S; Yaffe P; Ornoy A
    Birth Defects Res A Clin Mol Teratol; 2003 Jun; 67(6):429-37. PubMed ID: 12962287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered mitochondrial morphology of rat embryos in diabetic pregnancy.
    Yang X; Borg LA; Eriksson UJ
    Anat Rec; 1995 Feb; 241(2):255-67. PubMed ID: 7710141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological and physiological effects of beta-hydroxybutyrate on rat embryos grown in vitro at different stages.
    Moore DC; Stanisstreet M; Clarke CA
    Teratology; 1989 Sep; 40(3):237-51. PubMed ID: 2595599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A diabetes-like environment increases malformation rate and diminishes prostaglandin E(2) in rat embryos: reversal by administration of vitamin E and folic acid.
    Wentzel P; Eriksson UJ
    Birth Defects Res A Clin Mol Teratol; 2005 Jul; 73(7):506-11. PubMed ID: 15959876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal diabetes in vivo and high glucose concentration in vitro increases apoptosis in rat embryos.
    Gäreskog M; Cederberg J; Eriksson UJ; Wentzel P
    Reprod Toxicol; 2007 Jan; 23(1):63-74. PubMed ID: 17034987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between maternal metabolism and deranged development in the offspring of normal and diabetic rats.
    Styrud J; Thunberg L; Nybacka O; Eriksson UJ
    Pediatr Res; 1995 Mar; 37(3):343-53. PubMed ID: 7784144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and environmental influence on diabetic rat embryopathy.
    Ejdesjö A; Wentzel P; Eriksson UJ
    Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E454-67. PubMed ID: 21119026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary myo-inositol therapy in hyperglycemia-induced embryopathy.
    Khandelwal M; Reece EA; Wu YK; Borenstein M
    Teratology; 1998 Feb; 57(2):79-84. PubMed ID: 9562680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of reactive oxygen species (ROS) in the diabetes-induced anomalies in rat embryos in vitro: reduction in antioxidant enzymes and low-molecular-weight antioxidants (LMWA) may be the causative factor for increased anomalies.
    Ornoy A; Zaken V; Kohen R
    Teratology; 1999 Dec; 60(6):376-86. PubMed ID: 10590399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant N-acetylcysteine restores myocardial Mn-SOD activity and attenuates myocardial dysfunction in diabetic rats.
    Xia Z; Guo Z; Nagareddy PR; Yuen V; Yeung E; McNeill JH
    Eur J Pharmacol; 2006 Aug; 544(1-3):118-25. PubMed ID: 16859669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin treatment fails to abolish the teratogenic potential of serum from diabetic rats.
    Wentzel P; Eriksson UJ
    Eur J Endocrinol; 1996 Apr; 134(4):459-66. PubMed ID: 8640298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of genetic predisposition and maternal environment for the occurrence of congenital malformations in offspring of diabetic rats.
    Eriksson UJ
    Teratology; 1988 Apr; 37(4):365-74. PubMed ID: 3394110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sera from Cohen, genetically determined diabetic rats, streptozotocin diabetic rats and sucrose fed rats on in vitro development of early somite rat embryos.
    Ornoy A; Zusman I; Cohen AM; Shafrir E
    Diabetes Res; 1986 Jan; 3(1):43-51. PubMed ID: 3514068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamins C and E improve rat embryonic antioxidant defense mechanism in diabetic culture medium.
    Zaken V; Kohen R; Ornoy A
    Teratology; 2001 Jul; 64(1):33-44. PubMed ID: 11410909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats.
    Simán CM; Eriksson UJ
    Diabetologia; 1997 Dec; 40(12):1416-24. PubMed ID: 9447949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.